Heart Problems - Ongoing - Version: 0.8 Final Release Date: Q3/Q4 2024 Build Status: Release Candidate Previous Version: 0.7.3 (Hemodynamic Stabilization Patch) Next Milestone: 1.0 (Full Remission Protocol) 1. Executive Summary Welcome to Version 0.8 Final of the Ongoing Heart Problems case management framework. This release marks a critical inflection point between acute intervention and chronic long-term management. Unlike earlier iterations (0.1 – 0.6), which focused on emergency response, this version introduces a predictive maintenance model for cardiovascular function. For the patient (ID: 418-Kappa), this version represents 14 months of data aggregation, medication titration, and lifestyle kernel updates. The “Final” designation does not imply a cure—rather, it signals the stabilization of a previously volatile system. The “Ongoing” tag remains primary, acknowledging that heart problems, once symptomatic at this scale, transition from an incident to a persistent state . 2. Changelog: What’s New in 0.8 2.1 Added Features
Ejection Fraction (EF) Drift Monitoring: Real-time tracking of EF between 45% and 50% (up from a low of 35% in Version 0.4). Circadian Arrhythmia Logging: System now distinguishes between nocturnal vagal AFib (benign) and post-exertional tachyarrhythmia (actionable). Medication Response Matrix: Integrated beta-blocker (Metoprolol Succinate 100mg) sensitivity curve.
2.2 Fixed Bugs
Resolved: “False positive” chest pain stemming from costochondritis (non-cardiac origin) – reduced unnecessary ER visits by 62%. Resolved: Diuretic-induced hypokalemia (potassium floor raised to 4.1 mEq/L). Resolved: Syncope events during sudden postural changes (orthostatic hypotension patch applied successfully). Heart Problems -Ongoing- - Version- 0.8 Final
2.3 Known Issues (Legacy)
Fatigue remains a non-negotiable background process. Dyspnea on exertion (DOE) triggers unpredictably above 4 METs. Emotional stress crashes the system (high-priority for Version 0.9).
3. System Architecture: The Three-Layer Heart Model Version 0.8 Final conceptualizes heart problems not as a single disease but as three interacting subsystems: Layer 1: Structural (Hardware) Heart Problems - Ongoing - Version: 0
Condition: Non-ischemic cardiomyopathy, left ventricular hypertrophy (mild). 0.8 Status: Stable. No progression in LV mass index over 6 months. Intervention: ACE inhibitor (Lisinopril 10mg) + periodic echocardiograms Q6 months.
Layer 2: Electrical (Firmware)
Condition: Paroxysmal atrial fibrillation (PAF) burden ~4.2% per 72-hour Holter. 0.8 Status: Controlled but not eliminated. Ablation deferred (patient preference). Intervention: Flecainide 50mg BID as “pill-in-the-pocket” plus daily apixaban. Unlike earlier iterations (0
Layer 3: Perfusion (Runtime Environment)
Condition: Coronary microvascular dysfunction (CMD) – Type A pattern. 0.8 Status: Improved. Coronary flow reserve (CFR) increased from 2.1 to 2.4. Intervention: Ranolazine 500mg BID + regular zone 2 cardio training.